[1]Patent:US2011/184015,2011,A1
[1]CurrentPatentAssignee:ASTELLASPHARMAINC.-WO2021/87087,2021,A1Locationinpatent:Page/Pagecolumn111-112
1190312-37-8
4894-29-5
50503-75-8
117-77-1 | 2-Amino-3-hydroxyanthraquinone | AA000DFI | MFCD00059499
1171728-14-5 | 2-Amino-6-bromo-3-methylquinoline hydrochloride | AA000DQX | MFCD10703331
1173081-96-3 | 3-(Aminomethyl)-4,6-dimethyl-1h-pyridin-2-one, HCl | AA000E0G | MFCD09053337
114451-08-0 | 3H-Imidazo[4,5-f]quinoline, 3-methyl-2-nitro- | AA000EBJ | MFCD00468060
1147211-80-0 | 1H-Pyrazol-4-amine, 1-ethyl-5-methyl-, hydrochloride (1:2) | AA000F0F | MFCD04969122
114926-37-3 | L-3-Methylphenylalanine | AA000FE1 | MFCD00044972
1150163-69-1 | Methyl 5-bromo-2,3-difluorobenzoate | AA000FLH | MFCD12026006
1150703-55-1 | 1-(3-Fluorobenzyl)-5-methyl-1h-1,2,3-triazole-4-carboxylic acid | AA000FRR | MFCD17964756
115615-02-6 | 4-(Cyanomethyl)-2h-1,4-benzoxazin-3(4h)-one | AA000G6M | MFCD00268751
1153042-94-4 | 1-(2-Bromophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-ol | AA000GI2 | MFCD13193301